Sep 3, 2026 8:15 am EDT SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
Aug 31, 2026 7:30 am EDT SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers
Aug 6, 2026 8:30 am EDT SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET
Jul 30, 2026 2:04 pm EDT SRX Global Acquires Shares in Jersey Mike’s $1 Billion Initial Public Offering
Jul 10, 2026 8:30 am EDT SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
